Page last updated: 2024-08-26

phorbolol myristate acetate and naltrexone

phorbolol myristate acetate has been researched along with naltrexone in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DU, J; Gao, ZM; Jin, XL; Liang, R; Sun, DG; Tang, B; Wang, LM1

Other Studies

1 other study(ies) available for phorbolol myristate acetate and naltrexone

ArticleYear
[DADLE suppresses the proliferation of human liver cancer HepG2 cells by activation of PKC pathway and elevates the sensitivity to cis-diammine dichloridoplatium].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2012, Volume: 34, Issue:6

    Topics: Antineoplastic Agents; Cell Cycle; Cell Proliferation; Cisplatin; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enkephalin, Leucine-2-Alanine; Hep G2 Cells; Humans; Naltrexone; Phosphorylation; Protein Kinase C; Receptors, Opioid, delta; RNA, Messenger; Signal Transduction; Tetradecanoylphorbol Acetate

2012